Endogenous and Exogenous Estrogen, Cognitive Function, and Dementia in Postmenopausal Women: Evidence from Epidemiologic Studies and Clinical Trials

ABSTRACT

There are more than 200 published scientific papers showing that estrogen has favorable effects on brain tissue and physiology in cell culture and animal models including non-human primates. The biological plausibility for a neuroprotective estrogen effect is overwhelming. However, most studies of endogenous estrogen and cognitive decline or dementia in women fail to show protection, and some suggest harm. Failure to find any consistent association might reflect the limitations of a single time of estrogen assay or poor assay sensitivity. More than half of the observational studies of hormone therapy suggest benefit. Nearly all long-term clinical trials fail to show benefit, and the longer trials tend to show harm. Failure to adequately adjust for self-selection of healthier and wealthier women and publication bias could account for some, or all, of the protective effect attributed to estrogen in observational studies. Overall, the evidence does not convincingly support the prescription of early or late postmenopausal estrogen therapy to preserve cognitive function or prevent dementia.

KEYWORDS

Estrogen - cognitive function - dementia

REFERENCES

• 1 McEwen B S, Alves S E. Estrogen actions in the central nervous system.  Endocr Rev. 1999;  20 279-307
• 2 Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates.  Neuroscience. 2006;  138 859-867
• 3 Barrett-Connor E, Kritz-Silverstein D. Gender differences in cognitive function with age: the Rancho Bernardo study.  J Am Geriatr Soc. 1999;  47 159-164
• 4 de Frias C M, Nilsson L G, Herlitz A. Sex differences in cognition are stable over a 10-year period in adulthood and old age.  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006;  13 574-587
• 5 Aartsen M J, Martin M, Zimprich D. Gender differences in level and change in cognitive functioning. Results from the Longitudinal Aging Study Amsterdam.  Gerontology. 2004;  50 35-38
• 6 Hebert L E, Scherr P A, McCann J J, Beckett L A, Evans D A. Is the risk of developing Alzheimer's disease greater for women than for men?.  Am J Epidemiol. 2001;  153 132-136
• 7 Andersen K, Launer L J, Dewey M E et al.. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group.  Neurology. 1999;  53 1992-1997
• 8 Hankinson S E, Manson J E, Spiegelman D, Willett W C, Longcope C, Speizer F E. Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period.  Cancer Epidemiol Biomarkers Prev. 1995;  4 649-654
• 9 Pardridge W M, Mietus L J. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.  J Clin Invest. 1979;  64 145-154
• 10 Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women.  J Am Geriatr Soc. 1998;  46 816-821
• 11 Yaffe K, Lui L Y, Grady D, Cauley J, Kramer J, Cummings S R. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations.  Lancet. 2000;  356 708-712
• 12 Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women.  J Am Geriatr Soc. 1999;  47 1289-1293
• 13 den Heijer T, Geerlings M I, Hofman A et al.. Higher estrogen levels are not associated with larger hippocampi and better memory performance.  Arch Neurol. 2003;  60 213-220
• 14 Lebrun C E, van der Schouw Y T, de Jong F H, Pols H A, Grobbee D E, Lamberts S W. Endogenous oestrogens are related to cognition in healthy elderly women.  Clin Endocrinol (Oxf). 2005;  63 50-55
• 15 Hogervorst E, Williams J, Combrinck M, David Smith A. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.  Eur J Endocrinol. 2003;  148 67-72
• 16 Geerlings M I, Launer L J, de Jong F H et al.. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study.  Ann Neurol. 2003;  53 607-615
• 17 Low L F, Anstey K J, Jorm A F, Rodgers B, Christensen H. Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60–64 years.  Climacteric. 2005;  8 380-389
• 18 Henderson V W, Guthrie J R, Dudley E C, Burger H G, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women.  Neurology. 2003;  60 1369-1371
• 19 Geerlings M I, Ruitenberg A, Witteman J C et al.. Reproductive period and risk of dementia in postmenopausal women.  JAMA. 2001;  285 1475-1481
• 20 Yaffe K, Browner W, Cauley J, Launer L, Harris T. Association between bone mineral density and cognitive decline in older women.  J Am Geriatr Soc. 1999;  47 1176-1182
• 21 Lui L Y, Stone K, Cauley J A, Hillier T, Yaffe K. Bone loss predicts subsequent cognitive decline in older women: the Study of Osteoporotic Fractures.  J Am Geriatr Soc. 2003;  51 38-43
• 22 Sullivan Mitchell E, Fugate Woods N. Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study.  J Womens Health Gend Based Med. 2001;  10 351-362
• 23 Luetters C, Huang M H, Seeman T et al.. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).  J Womens Health (Larchmt). 2007;  16 331-344
• 24 Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause.  Menopause. 2007;  14 425-431
• 25 Kok H S, Kuh D, Cooper R et al.. Cognitive function across the life course and the menopausal transition in a British birth cohort.  Menopause. 2006;  13 19-27
• 26 Fuh J L, Wang S J, Lee S J, Lu S R, Juang K D. A longitudinal study of cognition change during early menopausal transition in a rural community.  Maturitas. 2006;  53 447-453
• 27 Elsabagh S, Hartley D E, File S E. Cognitive function in late versus early postmenopausal stage.  Maturitas. 2007;  56 84-93
• 28a Matthews K A, Kuller L H, Wing R R, Meilahn E N, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers?.  Am J Epidemiol. 1996;  143 971-978
• 28b Haskell S G, Richardson E D, Horwitz R I. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the lieterature.  J Clin Epidimiol. 1997;  50 1249-1264
• 29 Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.  Neuroscience. 2000;  101 485-512
• 30 LeBlanc E S, Janowsky J, Chan B K, Nelson H D. Hormone replacement therapy and cognition: systematic review and meta-analysis.  JAMA. 2001;  285 1489-1499
• 31 Kang J H, Weuve J, Grodstein F. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.  Neurology. 2004;  63 101-107
• 32 Matthews K, Cauley J, Yaffe K, Zmuda J M. Estrogen replacement therapy and cognitive decline in older community women.  J Am Geriatr Soc. 1999;  47 518-523
• 33 Rice M M, Graves A B, McCurry S M et al.. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project.  Arch Intern Med. 2000;  160 1641-1649
• 34 Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women.  JAMA. 1993;  269 2637-2641
• 35 Paganini-Hill A, Henderson V W. Estrogen replacement therapy and risk of Alzheimer disease.  Arch Intern Med. 1996;  156 2213-2217
• 36 Zandi P P, Carlson M C, Plassman B L et al.. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.  JAMA. 2002;  288 2123-2129
• 37 Seshadri S, Zornberg G L, Derby L E, Myers M W, Jick H, Drachman D A. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.  Arch Neurol. 2001;  58 435-440
• 38 Sherwin B B, Henry J F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.  Front Neuroendocrinol. 2008;  29 88-113
• 39 Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.  Obstet Gynecol. 1998;  91 459-466
• 40 Shaywitz S E, Shaywitz B A, Pugh K R et al.. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.  JAMA. 1999;  281 1197-1202
• 41 Duka T, Tasker R, McGowan J F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.  Psychopharmacology (Berl). 2000;  149 129-139
• 42 Yaffe K, Vittinghoff E, Ensrud K E et al.. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.  Arch Neurol. 2006;  63 945-950
• 43 Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.  Am J Med. 2002;  113 543-548
• 44 Espeland M A, Rapp S R, Shumaker S A et al.. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.  JAMA. 2004;  291 2959-2968
• 45 Resnick S M, Maki P M, Rapp S R et al.. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.  J Clin Endocrinol Metab. 2006;  91 1802-1810
• 46 Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women.  Cochrane Database Syst Rev. 2008;  (1) CD003122
• 47 Bagger Y Z, Tanko L B, Alexandersen P, Qin G, Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life.  Menopause. 2005;  12 12-17
• 48 Petitti D B, Crooks V C, Chiu V, Buckwalter J G, Chui H C. Incidence of dementia in long-term hormone users.  Am J Epidemiol. 2008;  167 692-700
• 49 Tang M X, Jacobs D, Stern Y et al.. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.  Lancet. 1996;  348 429-432